DRUG-DRUG INTERACTION
Clinical trials for DRUG-DRUG INTERACTION explained in plain language.
Never miss a new study
Get alerted when new DRUG-DRUG INTERACTION trials appear
Sign up with your email to follow new studies for DRUG-DRUG INTERACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection Y-3 put to the test: will it clash with common drugs?
Knowledge-focused CompletedThis completed Phase 1 trial in 24 healthy adults checked whether an experimental injection called Y-3 changes how the body handles three common drugs: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Participants took these drugs alone and …
Matched conditions: DRUG-DRUG INTERACTION
Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Healthy volunteers help uncover drug interactions for KBP-5074
Knowledge-focused CompletedThis early-stage study looked at how two common drugs—itraconazole (a fungal treatment) and rifampin (an antibiotic)—change the way the body processes KBP-5074, a potential medicine for high blood pressure or kidney disease. Twenty-four healthy adults took a single dose of KBP-50…
Matched conditions: DRUG-DRUG INTERACTION
Phase: PHASE1 • Sponsor: KBP Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC